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Bioactive peptides are present in all metazoan species where they orchestrate diverse func-
tions.  In the last decade, high-throughput approaches based on mass spectrometry helped
the identiﬁcation of endogenously occurring peptides in different species. We here review
biochemical strategies to obtain sequence information of natural (non-tryptic) peptides
in  Caenorhabditis elegans and in the related nematodes Caenorhabditis briggsae and Ascaris
suum with particular attention for sample preparation and methodology. In addition, we
describe seven new C. elegans neuropeptides that we recently discovered by sequencingInsulin
Neuropeptide
Processing enzyme
additional peptides. Finally, we explain how differential peptidomics approaches were used
to  characterize key neuropeptide processing enzymes.
©  2014 The Authors. Published by Elsevier B.V. on behalf of European Proteomics
Association (EuPA). This is an open access article under the CC BY-NC-ND license
cal synapses and gap junctions. In this respect, it is very likely1.  Introduction
The nematode Caenorhabditis elegans is a common model
system in neuroscience research for several reasons. It was
the ﬁrst multicellular organism from which the genome was
entirely sequenced. Comparison of C. elegans genes with ver-
tebrate homologues showed many  similarities [1,2]. In fact,
essential neuronal processes and functions (including neu-
rotransmission at chemical synapses, electrical signalling
through gap junctions and extrasynaptic communications
via neuropeptides) are highly conserved among all animals.
The hermaphrodite nematode has exactly 302 neurons of
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which the cell lineage and exact physical locations are known.
Reconstructions of electron micrographs allowed mapping all
synaptic connections and gap junctions and as such, the ner-
vous system can be considered as “hard wired” [3]. However,
predicting behavioural output solely based on the wiring dia-
gram is not straightforward, especially as synapses can be
excitatory or inhibitory. In addition, slow-acting transmitters
such as neuropeptides should be considered as a third layer of
information ﬂow in neuronal communication, next to chemi-esearch (SPHERE), Department of Biology, University of Antwerp,
.
that nearly all neurons secrete neuropeptides and many  roles
for peptides in key physiological processes and behaviours
have been characterized [4–6].
 European Proteomics Association (EuPA). This is an open access
enses/by-nc-nd/3.0/).
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We  here review the efforts that have been undertaken to
eveal the rich diversity of neuropeptide-encoding genes, neu-
opeptide processing enzymes, the resulting bioactive peptide
equences and characterization of GPCRs that ultimately
ided further functional elucidation of selected neuropep-
idergic signalling systems in C. elegans.
.  Three  families  of  neuropeptide-encoding
enes
.1.  FMRFamide-like  peptides  (FLP)
n C. elegans, three families of neuropeptides or neuropeptide-
ncoding genes are generally considered. Bioactive peptides
isplaying carboxyterminal sequence similarity with the car-
ioexcitatory peptide FMRFamide, which was ﬁrst discovered
n a bivalve mollusk [7], belong to the family of FMRFamide-like
eptides (FLP), also referred to as FMRFamide-related peptides
FaRP). This diverse family is widely represented in various
etazoan species [8], including insects [9], nematodes [10,11]
nd platyhelminths [12]. Whole mount immunocytochemistry
sing antibodies that recognize the carboxyterminal signature
f FaRPs allowed visualization of immunoreactive neurons in
. elegans, hereby suggesting the presence of FaRPs in the
ematode [13–16]. Indeed, bioinformatics surveys of cDNA
ibraries and BLAST allowed uncovering nearly 30 ﬂp genes
n C. elegans.  ﬂp-1 to ﬂp-23 and ﬂp-28 were found by the group
f Chris Li [6,16–19], while the lab of Aaron Maule reported the
dentiﬁcation of ﬂp-24 to ﬂp-27 and ﬂp-32 [10,11]. In addition,
eptides from ﬂp-24, ﬂp-26, ﬂp-33 and ﬂp-34 could be detected
y LC–MS-based peptidomics approaches in the Schoofs group
20,21] (see further).
.2.  Insulins  (INS)
 second family comprises 40 peptides (INS-1 to INS-39 and
AF-28) with sequence resemblance with insulin [22–25].
xpression of ins-1 through ins-31 and ins-33 have been con-
rmed on the level of cDNA sequences and reporter constructs
evealed cellular localization patterns for 15 ins genes [25,26].
evertheless, no single C. elegans INS peptide has ever been
iochemically characterized.
.3.  Neuropeptide-like  proteins  (NLP)
he so-called neuropeptide-like protein (nlp) genes were ini-
ially identiﬁed in C. elegans by the group of Anne Hart [27] and
n other nematodes by the Maule lab [28] based on structural
riteria and sequence resemblance with peptides (e.g. allato-
tatin, myomodulin, buccalin, orcokinin) from other species.
his way, 32 nlp genes were identiﬁed and expression patterns
ere examined using GFP reporter constructs. Resulting pep-
ides can be further subdivided based on sequence motifs like
AFA, GGXY-amide, MRX-amide, LQF-amide, LXDX-amide and
GARAF. Interestingly, some nlp genes appear to be expressed
n the epidermis and especially nlp-29,  nlp-31 and nlp-33 were
ifferentially regulated in the event of a fungal and/or bacte-
ial infection. They were therefore considered as antimicrobial
eptides (AMP), as are the structurally related caenacins (CNC) ( 2 0 1 4 ) 280–290 281
[29,30]. Obviously, AMPs, including some NLPs, CNCs, ABF
peptides, fungus-induced peptides (FIP) and FIP-related (FIPR)
peptides should be considered as naturally occurring bioac-
tive peptides, but are discussed elsewhere [31]. Later-on, many
additional NLP peptide-encoding genes (until nlp-52)  could be
identiﬁed by further mining the C. elegans genome and by
using LC–MS based peptidomics approaches [20,28,32–34] (see
below).
3.  Biochemical  characterization  of  FLP  and
NLP  peptides
3.1.  Classical  biochemical  approaches
As explained before, a lot of efforts mining EST libraries
or genomic data allowed identiﬁcations of numerous
neuropeptide-encoding genes. However, it is still hard to
predict exact sequences of the encoded bioactive peptides.
Traditionally and before the genomics era, bioactive pep-
tides were typically identiﬁed and characterized by screening
of HPLC fractions using a dedicated (bio)assay. After several
rounds of chromatographic separations, the active compound
could be puriﬁed and sequence identity was revealed by
Edman degradation. In doing so, 12 FLP peptides could be iden-
tiﬁed by radioimmunological screening of peptide extracts
from C. elegans [35–40]. Using similar approaches, 20 FLP pep-
tides could be isolated from the larger nematode Ascaris suum
where they are annotated as AF peptides [41–44].
3.2.  C.  elegans  peptidomics  using  2D-nanoLC  Q-TOF
MS/MS
To reveal peptide sequences in a high-throughput manner, a
peptidomics approach combining two-dimensional nanoscale
liquid chromatography (2D-nanoLC) and quadrupole time-
of-ﬂight tandem mass spectrometry (Q-TOF MS/MS) was
performed in the Schoofs lab. This setup, as depicted in
Fig. 1, was ﬁrst optimized when exploring the neuropeptidome
of the fruitﬂy D. melanogaster [45,46]. A detailed protocol to
extract naturally occurring peptides from C. elegans can be
found in [47]. In short, worms were placed in an acidiﬁed
methanolic extraction solvent (methanol/water/acetic acid
90/9/1), homogenized and sonicated prior to centrifugation.
The pellet was discarded and methanol was evaporated using
a Speed Vac concentrator. Next, the aqueous residue was
delipidated by liquid–liquid extraction with an equal volume
of ethyl acetate or n-hexane. Finally, the peptide extract was
desalted by solid phase extraction.
In total, 60 peptides could be identiﬁed, including pep-
tides missed by the initial bioinformatics surveys [20]. Though
accurate sequences of many  of the previously predicted pep-
tides could be conﬁrmed, shorter or longer forms could
also be observed. For example, AMDSPLIRFamide from the
FLP-13 precursor was found, though the longer form, SDRP-
TRAMDSPLIRFamide, was initially predicted. Probably the
arginine residue at position six acts as a monobasic cleavage
site to be recognized by proprotein convertases (see below).
Revisiting these 2D-nanoLC MS/MS data allowed character-
izing two additional peptides that were initially overlooked.
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Fig. 1 – 2D nanoLC Q-TOF MS/MS  workﬂow for C. elegans peptidomics. Initial C. elegans peptidomics experiments were
performed using an Ultimate HPLC pump, a Switchos column-switching device and a Famos autosampler (all LC Packings).
This LC-setup (A) was coupled to a Q-TOF hybrid Quadrupole time-of-ﬂight mass spectrometer (Micromass), as described in
[20]; total ion currents (TIC) are shown in (B). Peptides that were  ﬁrst loaded on a strong cation exchange (SCX) column
(Bio-SCX, 500 m × 15 mm,  LC-Packings) could be eluted by 10 salt plugs ranging from 0 to 2000 mM of ammonium acetate.
Next, each fraction underwent a second separation on a nanoscale C18 column (3 m,  100 m × 100 mm,  Atlantis, Waters)
using a 50 min  gradient to 50% ACN containing 0.1% FA at a ﬂow rate of 200 nl/min. The column eluent was directly
connected to the electrospray (ESI) source of the Q-TOF instrument that automatically selected doubly and triply charged
hres
 to Mparent ions when intensities increased above a predeﬁned t
data were  transformed into peak list ﬁles (E) to be submitted
GVGDVPSMFFSPFRMMamide originates from the C38C10.6
precursor that we  propose to name NLP-48. This peptide is
ﬂanked by a RX2R at the aminoterminus and by (G)KR at the
carboxyterminus. SPSMGLSLAEYMASPQGGDNFHFMPSamide
is contained in the H05L03.3 gene product which we propose
to name NLP-49 and which is, respectively, ﬂanked by KR and
(G)RK at amino- and carboxytermini. Both new neuropeptide
precursors contain a signal peptide recognized by SignalP 4.0
(http://www.cbs.dtu.dk/services/SignalP-4.0) (Fig. 2A).
3.3.  Identiﬁcation  of  ﬁve  novel  peptides  in  C.  elegans
by off-line  HPLC–MALDI  TOF/TOF  MS
Some peptides ionize more  efﬁcient by matrix-assisted laser
desorption ionization (MALDI) compared to ESI, and vica
versa. Hence, additional peptides can be identiﬁed by employ-
ing another peptidomics workﬂow where HPLC fractions are
collected and analyzed by MALDI-TOF MS/MS. (Ultraﬂex II,
Bruker Daltonics). This simple, though robust approach was
also used to explore the peptidome of the related nematode
Caenorhabditis briggsae [48] and to compare peptide proﬁles
from different C. elegans strains with defective neuropeptide
processing enzymes [21,49–51], as explained later-on. Ion
peaks were initially annotated by comparing the masses of
the ions detected with the theoretical masses of in silicohold for fragmentation aided by argon gas (C and D). MS/MS
ascot as search engine (F).
predicted (and previously identiﬁed) neuropeptides. To obtain
sequence information, selected ions were fragmented and
resulting peak list ﬁles were submitted to a database search
(using mascot) against the protein database of C. elegans
(Matrix Science). Doing so, we here report the identiﬁca-
tion of ﬁve novel (neuro)peptides: TEGLSRASANAYYRLamide
originates from the F41G3.1 precursor that we  would like to
annotate as NLP-50; SQTQEANIQPFIRF (note that no amide
is present at the carboxyterminus) originates from T24F1.5
that we would like to annotate as NLP-51; GDVKSVFFSPFRM-
Vamide is contained in the F42G9.4 precursor that we  propose
to name NLP-52. Finally, ADISTFASAINNAGRLRYamide and
ALNRDSLVASLNNAERLRFamide are contained in the R09A1.5
precursor that we  would like to name FLP-34, as the last
peptide contains the typical RFamide motif at the carboxyter-
minus. All new neuropeptide precursors contain a signal
peptide as veriﬁed by SignalP 4.0 (Fig. 2A and B–F shows frag-
mentation spectra).
3.4.  Peptidomics  of  the  related  nematode  C.  briggsae
by off-line  HPLC–MALDI  TOF  MSC. briggsae is the closest studied species of nematode to C.
elegans and shares the hermaphroditic mode of reproduc-
tion. They diverged about 100 million years ago and are
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Fig. 2 – New C. elegans neuropeptides. We here report the identiﬁcation of 7 new neuropeptides that originate from 5 NLP
precursors and 1 FLP precursor, as displayed in (A). The signal sequence is shown in italics, dibasic cleavage motifs are
underlined and the identiﬁed peptide is in bold. Peptides from NLP-48 and NLP-49 could be identiﬁed by resubmitting
previously generated 2D nanoLC MS/MS data [20] to an updated C. elegans protein database. Additional peptides could be
identiﬁed by off-line HPLC MALDI-TOF/TOF MS; see (B-F) for resulting fragmentation spectra. Extracts were  separated on a
Symmetry C18 column (2.1 mm × 150 mm,  3.5 m at a ﬂow rate of 300 L/min) using a linear gradient from 2 to ∼50% ACN
containing 0.1% TFA in 60 min  to allow collecting 60 fractions. About ½ of the fractions were  dried in a Speed Vac
concentrator and resuspended in 1 L MQ/ACN/TFA (50/49.9/0.1) to be spotted on the stainless steel MALDI target plate and
mixed with 1 L of matrix consisting of a saturated solution of -cyano-4-hydroxy cinnamic acid in acetone. Spectra were
recorded in MS  mode using an UltraﬂexII instrument (Bruker Daltonics), within a mass range from m/z  500 to m/z  3000 or
4000. For initial annotation of ion peaks, we used a custom-made software programme, VglP, which automatically
compares the generated peak list ﬁles with the theoretical masses of in silico predicted (and previously identiﬁed)
neuropeptides. In order to obtain sequence information, selected ion peaks were  fragmented using an optimized LIFT
(TOF/TOF) procedure. Next, all MS/MS  spectra were automatically processed (background subtraction, smoothing and peak
picking; by using FlexAnalysis, Bruker Daltonics) to generate peak list ﬁles to be submitted to a “Mascot” search against the
protein database of C. elegans (matrix science).
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nearly morphologically identical (for an un-experienced eye).
Surprisingly, however, its genomic sequence revealed many
differences [52–55]. As 5 years ago no neuropeptide genes
were annotated in the C. briggsae genome, its peptidome was
explored by combining in silico analysis with LC–MS to iden-
tify 27 ﬂp and 31 nlp genes [48]. Off-line screening of HPLC
fractions by MALDI-TOF MS  (as explained above) revealed the
presence of 37 FLP peptides and 22 NLP peptides. In addition,
this peptidomics approach allowed obtaining better insights
on splicing of (sometimes wrongly) predicted exons. For exam-
ple, the peptide SPAQWQRANGLWamide containing a typical
W(X)6 Wamide motif that is also present in the myoinhibiting
peptides (MIPs) from insects, was initially found in C. elegans
by LC–MS/MS [20] and is encoded by the last exon of nlp-38.
Although this peptide did not appear to be present in the
predicted C. briggsae homologue, the same MIP-like peptide
could be sequenced from a peptide extract of C. briggsae. As
the corresponding DNA sequence could be (manually) found
in the same nucleotide sequence contig, it is likely that the
last exon of the C. briggsae neuropeptide precursor gene was
not annotated as such due to wrong in silico splicing.
3.5.  Direct  peptide  proﬁling  of  A.  suum  tissues  by
MALDI-TOF,  -TOF/TOF  or  ICR-FT  MS
The parasitic nematode A. suum contains 298 neurons and
is signiﬁcantly larger than C. elegans, facilitating physiolog-
ical characterizations of neurons and muscles. As already
mentioned above, 20 endogenous peptides could be biochem-
ically characterized from this large roundworm by classical
puriﬁcation strategies and monitoring reactivity with a poly-
clonal antibody against the FMRFamide motif [41–43]. About
ten years ago, three additional AF peptides were sequenced
directly from the tissue by MALDI-TOF MS  [56]. Direct peptide
proﬁling of dissected neuronal Ascaris tissues allowed spatial
mapping of known and predicted peptides without the need
for extensive extraction procedures [56,57]. In 2005, the Stret-
ton group was able to identify 41 peptides originating from
the nerve ring (NR), ventral ganglion (VG), retrovesicular gan-
glia (RVG), dorsal ganglion (DG), lateral line ganglia (LLG) the
ventral and dorsal nerve cords (VC, DC) and ventrodorsal com-
missures (VDCs) by employing a MALDI-TOF (Reﬂex II, Bruker
Daltonics), MALDI-TOF/TOF (UltraﬂexII, Bruker Daltonics) or a
MALDI-FT (Ion Spec Fourier Transform MS, equipped with a
7 T magnet and ability for sustained off-resonance irradiation
and collision-induced dissociation (SORI-CID)). Assignments
of peptide sequences were made when the observed m/z value
was within 0.5 Da; 0.2 Da or 0.001 Da (as measured on the
Reﬂex II, Ultraﬂex or FT instrument, respectively) of the the-
oretical values of the peptides. In the event that the mass of
a peptide is not a unique identiﬁer to unambiguously assign
a peptide sequence, additional conﬁdence was gained from
chemical derivatizations (i.e. acetylation of primary amine
groups and oxidation of methionines) performed on the tis-
sues prior to MS  analysis. Peptide proﬁles from different
neuronal structures showed signiﬁcant overlap in the pep-
tide content, though distinct peptides could be observed for
each tissue. In general, the NR, VG and RVG exhibited the
largest spectra complexities and intensities, in contrast to the
low signal-to-noise ratios in spectra obtained from the VDCs, 3 ( 2 0 1 4 ) 280–290
which is likely due to low peptide abundances. Five years
later, the Stretton group was able to map  neuropeptide expres-
sion in single dissected neurons (ALA and RID) from the DG
[58], where the availability of genome survey sequences (GSSs)
have been extremely helpful in aiding de novo sequencing.
Similarly, several peptides could be measured in AVK neu-
rons by MS and their presence could be conﬁrmed by in situ
hybridization and immunocytochemistry [59].
3.6.  Peptidomics  of  A.  suum  by  data  mining  and
nanoLC–LTQ  Orbitrap  MS/MS
After publication of the draft genome sequence of Ascaris
[60], the Stretton group combined an in silico data mining
approach with a high-throughput peptidomics experiment
to report 21 novel peptides, in addition to many previously
identiﬁed peptides [61]. Heads were freeze-powdered and
peptides were extracted using the “typical” 90/9/1-extraction
solvent (methanol/water/acetic acid) as indicated above, fol-
lowed by delipidation by liquid–liquid extraction with 15/85
ethyl acetate/hexane and solid phase extraction using C18
cartridges. Finally, size exclusion separations were performed
to remove proteins. For LC–MS analysis, the nanoLC system
(nanoAcquity, Waters) was connected to an ESI FT/ion-trap MS
instrument (LTQ Orbitrap Velos, Thermo Fisher Scientiﬁc) and
MS/MS data from collision induced dissociation (CID), high
energy collision dissociation (HCD) and electron transfer dis-
sociation (ETD) were searched against an in-house peptide
database using SEQUEST or Mascot. Overall, sequences of pre-
viously identiﬁed or predicted peptides could be conﬁrmed,
though shorter forms or incompletely processed variants were
also found, similar to previous results obtained from C. elegans
[20]. For example, the A. suum peptide ENEKKAVPGVLRFamide
results from an incomplete cleavage of AF3. In contrast,
LM(oxidized)DPLIRFamide is a shorter form or fragment of
AF34 (DSKLMDPLIRFamide), which is encoded by afp-13.  The
internal lysine at position three of AF34 thus likely acts as
a monobasic cleavage site to be recognized by proprotein
convertases or other enzymes. Alternatively, the full-length
peptide might have been subject to in vivo or in vitro degrada-
tion, hereby yielding a truncated peptide.
4.  Characterization  of  neuropeptide
processing  enzymes
4.1.  Biosynthesis  of  bioactive  peptides:  insights  from
peptidomics  experiments  in  other  organisms
As exempliﬁed above, mining the genome for neuropeptide-
encoding genes and in silico prediction of accurate peptide
sequences is not straightforward, especially as biosynthe-
sis of bioactive peptides requires multiple post-translational
processing steps. By characterizing genes required for neu-
ropeptide biosynthesis, speciﬁc roles can be identiﬁed for
neuropeptides in the generation of behaviour in vivo. In addi-
tion, processing enzymes are considered to be attractive
targets for the development of powerful novel therapeutics
[62]. The formation of bioactive peptides is a multistep process
that starts with the synthesis of larger inactive preproproteins
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r peptide precursors in the endoplasmic reticulum. First,
he aminoterminal signal peptide is chopped off from the
nactive proprotein precursor protein after entry into the
ecretory pathway. Next, proprotein convertases (PC) recog-
ize typical cleavage motifs consisting of basic residues like
rginine and lysine. KR and RR are mainly observed, while
K, KK or (R/K)X2/4/6/8(R/K) are found in lower frequency [63].
n mammals, 7 PCs (furin, PC1/3, PC2, PC4, PC5/6, PC7/8/LPC
nd PACE4) have been described [64–66]; all of which show
equence similarity to the yeast prototype Kex2p [67]. PC2 and
C1/3 recognize substrates with dibasic residues and are thus
ey PCs needed for the processing of neuropeptide precur-
ors [64–66]. Indeed, peptidomics analysis of PC1/3 [68] and
C2 [69] knockout mice revealed clear reductions of neuro-
eptides present. Comparison and analysis of cleavage motifs
evealed that while PC1/3 and PC2 have redundant substrate
references; preferences for each PC can be distinguished by
articular site residues. In the fruitﬂy, three subtilisin-like
nzymes appear to be present, of which amontillado (amon)
ncodes for the Drosophila PC2 homolog; a PC1/3 homolog
eems to be lacking [70]. By semi-quantitative MALDI-TOF
ass spectrometric proﬁling in combination with genetics
nd immunostainings, AMON was proven to be the major neu-
opeptide processing proprotein convertase in the CNS of the
ruitﬂy [71]. In addition, all entero-endocrine peptides from
he Drosophila midgut seemed to be processed by AMON as
ell, as respective mutants display a strongly impaired pep-
ide proﬁle [72].
In general, PC2 requires proteolytic activation by the
minoterminal part of the chaperone protein 7B2, while the
arboxyterminal fragment of 7B2 functions to inhibit the
ctivity of PC2 [73,74]. Interestingly, deﬁciency of 7B2 does not
imic  phenotypes observed in PC2 knock-out mice models.
B2-null mice die early from Cushing’s disease in addition
o many  other atypical symptoms [75], while PC2-null mice,
hough having a different genetic background [76], are viable
77]. In line with these phenotypically differences, striking
ifferences in peptide proﬁles could be observed in PC2-null
nd 7B2-null mice [75,77]. Drosophila PC2 (AMON) also requires
B2 for its activation [78], though further evidence from pep-
idomics experiments is lacking. Recently, 7B2 was also shown
o suppress formation of amyloid- (A)-derived peptides
nd -synuclein aggregation, which are characteristic for
he neurodegenerative diseases Alzheimer and Parkinson,
espectively [79].
After cleavage of the proprotein peptide precursor at basic
ecognition motifs by PCs, the resulting intermediate peptides
re further processed by a carboxypeptidase that chops off the
arboxyterminal basic amino acids. Mammalian carboxypep-
idase E (CPE) was initially discovered in 1982 as enkephalin
onvertase [80] and belongs to the metallocarboxypeptidase
amily. Mice containing a (Ser202Pro) mutation in the CPE gene
Cpefat/fat) slowly develop obesity and mild type II diabetes [81].
igh-throughput peptidomics analysis of Cpefat/fat mice indeed
evealed carboxyterminally extended intermediate peptides
n addition to fully processed mature peptides, which are likely
ue to the activity of carboxypeptidase D [82–87].
Most bioactive neuropeptides are amidated at the car-
oxyterminus, which likely improves peptide stability and
eceptor recognition. This post-translational modiﬁcation ( 2 0 1 4 ) 280–290 285
results from a multistep reaction that involves a hydroxylation
of the glycine -carbon by peptidyl--hydroxylating monooxy-
genase (PHM), followed by a cleavage reaction performed by
peptidyl -hydroxyglycine -amidating lyase (PAL) to generate
the -amidated peptide and glyoxylate. In higher organisms,
both enzymatic reactions are mediated by a bifunctional
enzyme, peptidylglycine alpha-amidating monooxygenase
(PAM) [88,89], while many  invertebrates contain two  distinct
enzymes (PHM and PAL), that are encoded by different genes
[90]. To our knowledge, no high-throughput peptidomics anal-
yses have been reported on amidation mutants. However, a
so-called “precursor and -amidated peptide pairing” (PAPP)
approach was recently described to reduce interpretation and
computing time for database searching to identify -amidated
peptides from AtT-20 cells. Cells were cultured in the pres-
ence of a PAM inhibitor to enable the coexistence of fully
processed -amidated peptides and their glycine-extended
precursor peptides, which differ 58 Da in mass but exhibit sim-
ilar retention times and fragmentation patterns [91].
4.2.  Characterization  of  peptide  processing  enzymes  in
C. elegans  by  differential  peptidomics
Though the neuropeptide processing pathway has been
characterized in many  other organisms, little was known
about the processing enzymes in C. elegans. Therefore,
a simple though straightforward differential peptidomics
approach was employed in the Schoofs lab to characterize key
processing enzymes in C. elegans (Fig. 3). Brieﬂy, peptides from
C. elegans lines having a mutation in the presumed processing
enzyme-encoding gene were monitored by LC–MALDI TOF MS
as explained above. Though this strategy was not quantitative,
it allowed easy comparison of peptide proﬁles to verify which
genes are involved in the neuropeptide processing pathway.
In C. elegans, four genes were discovered that encode
kex2-like proprotein convertases (KPC) by mining genome
sequences and cDNA clones [2,92–96]. C. elegans KPC-2 is also
named EGL-3 as mutants were initially discovered in a genetic
screen for egg-laying deﬁciency about 30 years ago [97]. KPC-2
(or EGL-3) was initially suggested to be essential for neuro-
peptide processing by the Kaplan group [94]. When monitoring
the peptide content of different kpc-2 (or egl-3) mutants by
mass spectrometry, very little ions corresponding in mass to
neuropeptides could be observed, implying that the encoded
enzyme is indeed required for the proper processing of bioac-
tive peptides in C. elegans [49]. The involvement of C. elegans
7B2 (SBT-1, standing for Seven-B-Two) in the biosynthesis of at
least some FLP and NLP peptides could also be demonstrated
using a similar differential peptidomics approach [21].
Mutants for the egl-21 gene were found in the genetic
screen for egg laying deﬁciency that also yielded egl-3 (or kpc-
2) mutants [97]. Sequence similarity with carboxypeptidase E
and a decreased immunoreactivity for the anti-RFamide anti-
body previously pointed to a role in the processing of FLP
precursors [98]. 2D-nanoLC Q-TOF MS/MS analysis of egl-21
mutants revealed 48 intermediate peptides with the basic
amino acids still attached at the carboxyterminus, of which
37 NLPs and 11 FLPs; only 4 fully processed peptides could be
detected [50]. When using the LC–MALDI-TOF MS  approach,
90 carboxy-terminally extended peptides were identiﬁed in
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Fig. 3 – Characterization of neuropeptide processing enzymes in C. elegans. (A) Biosynthesis of (neuro)peptides requires
extensive post-translational processing of an inactive peptide precursor protein. Comparison of MALDI-TOF MS spectra of
corresponding LC fractions obtained from extracts from a proprotein convertase (KPC-2) mutant egl-3(n729) (B), a 7B2 mutant
1) (Dsbt-1(ok901) (C) and a carboxypeptidase E mutant egl-21(n61
these key processing enzymes [21,49,50].
addition to 24 fully processed peptides, which suggest the
presence of an additional carboxypeptidase that acts redun-
dantly or in parallel. We  are currently characterizing mutants
defective for presumed amidation enzymes.
5.  Characterization  of  neuropeptide  GPCRs
in  C.  elegans  and  functionality
As indicated above, efforts of bioinformatics and biochem-
istry allowed identifying numerous peptidergic signalling
molecules in the nematodes C. elegans, C. briggsae and A. suum,
which is essential for identiﬁcation and characterization of
cognate G protein-coupled receptors (GPCRs) and further elu-
cidation of signalling cascades that ultimately regulate diverse
behaviours.
About 50 peptide receptors were initially mined from the
C. elegans genome, based on sequence similarity with neu-
ropeptide GPCRs from insects or vertebrates [1,2]. A number
of them appeared to be involved in locomotion or reproduc-
tion, as determined by gene silencing using RNA interference
[99]. However, 125 putative peptide GPCRs could be detected
when using known peptide GPCRs as input sequences in a
Multiple Expectation Maximization for Motif Elicitation/Motif
Alignment and Search Tool (MEME/MAST) analysis [100]. This
impressive list was recently reﬁned by further updating the
seeding set [4]. In order to ﬁnd the cognate ligand of a recep-
tor of interest, so-called reversed pharmacology approaches
can be applied [101]. In short, the orphan GPCR is expressed
in a heterologous expression system like Chinese hamster) with wild type C. elegans (E) allowed characterization of
ovary (CHO) cells or human embryonic kidney (HEK) cells that
also express a promiscuous G protein like the G16 subunit
to yield a calcium ﬂux that can be measured upon activa-
tion of the receptor. Cells are subsequently challenged with
a library of synthetic peptides or fractionated peptide extrac-
tions. Calcium increases can be monitored by employing
bioluminescent proteins like aequorin or by using ﬂuorescent
calcium indicators like Fluo-4. Alternatively, Xenopus oocytes
can be used as cellular expression system in which gating of
the co-expressed GIRK1 channel that interacts with free G is
measured by whole-cell voltage-clamp recordings upon recep-
tor activation. Doing so, a total of 23 C. elegans GPCRs could be
deorphanized (including splice variants). A thorough descrip-
tion of these GPCRs and their functionality in diverse physio-
logical and behavioural pathways was recently reviewed [4].
6.  Future  directions:  towards  functional
studies
Nematodes can exhibit a rich repertoire of different
behavioural output responses upon diverse internal and
external cues (including chemotaxis, thermotaxis, oxygen
sensing and even associative learning). Understanding the
neuronal substrates and mechanisms underlying signal input,
processing and signal output, to ultimately direct proper
behaviour, can be considered as an important goal in fun-
damental neuroscience. In recent years, distinct advances
were made in the functional elucidation of deﬁned peptider-
gic signalling systems in the model nematode C. elegans by
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xploiting its advanced genetics toolkit in combination with
ifferent state-of-the-art techniques like Ca2+ imaging and
ptogenetics approaches.
Early experiments to probe the function of individual
eurons mainly utilized the connectome diagram to select
ndividual cells to be ablated with a focused laser beam in
rder to infer its role in a speciﬁc behavioural paradigm. Nowa-
ays, optogenetics approaches allows researchers to reversibly
ctivate and/or inhibit selected neurons in a time-resolved
anner by simple illumination of the worm with blue, green
r yellow light [102,103] while the activity of downstream neu-
ons can be monitored by adopting Ca2+ imaging techniques
104–106]. In addition, automated tracking systems or video
nalysis tools are employed to monitor behavioural output
107]. However, it is important to note that most of these stud-
es still rely on early knowledge from the mapped connectome
r wiring diagram, while important neuronal communication
s also achieved by means of slow-acting transmitters such as
europeptides or biogenic amines that act beyond the neu-
onal synapses. Indeed, recent studies revealed that deﬁned
eptidergic signalling systems are required for ﬁne-tuning or
odulation of speciﬁc aspects of behaviour; see [4] for an
xtensive overview of all functionally described peptidergic
ignalling pathways in C. elegans. These recent advances in the
unctional elucidation of peptidergic modulation of neuronal
ircuits were possible by the ever-increasing technological
latforms to probe the nervous system, but also relied on
he availability of accurate peptide sequence information as
evealed by peptidomics experiments.
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